Held from 2 to 4 June, the inaugural Durham and Singapore Horizon summit, or DASH, brought together faculty and leaders from Duke University, Duke-NUS and the SingHealth Duke-NUS Academic Medical Centre.
Designed to build sustained research and education collaborations, DASH convened experts from academia, healthcare, industry and philanthropy around shared priorities including integrated data tools for precision medicine and nucleic acid therapeutics.
Rather than relying on collaborations to emerge incidentally, DASH aims to create a more deliberate pathway through which promising ideas can be developed, supported and moved towards real-world impact.
“The goal is to establish collaborative work that is greater than any one institution,” said Professor Mary Klotman, executive vice president for health affairs at Duke University, dean of Duke University School of Medicine , and chief academic officer for Duke Health. “Work that can grow, scale and ultimately attract the support needed to make a lasting impact.”
Professor Victor Dzau, President of the US National Academy of Medicine, noted that the summit coincided with the 60th anniversary of diplomatic relations between Singapore and the United States, underscoring the wider significance of cross-Pacific scientific and medical partnership.
DASH now provides a foundation for teams across Durham and Singapore to continue developing projects beyond the summit itself.